<?xml version="1.0" encoding="UTF-8"?>
<ref id="B111-viruses-12-01058">
 <label>111.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Drilon</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Camidge</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Ou</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Socinski</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Weiss</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Riely</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Winter</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Monti</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC)</article-title>
  <source>J. Clin. Oncol.</source>
  <year>2016</year>
  <volume>34</volume>
  <fpage>108</fpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2016.34.15_suppl.108</pub-id>
 </element-citation>
</ref>
